Nevertheless, studies investigating the consequences of inhibiting necroptosis through targeting either RIPK3 or MLKL in mice have presented contradictory outcomes concerning inflammation, steatosis, and fibrosis, with the observed effects varying based on the dietary conditions [40,41,42,43]. The gene discussed is RIPK3; the disease is steatosis.